WHO ICTRP trial

Treatment of central sleep apnoea and Cheyne Stokes respiration in patients with…

NL-OMON47575 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting

Key facts

Trial ID NL-OMON47575
Public title Treatment of central sleep apnoea and Cheyne Stokes respiration in patients with heart failure: nasal high-flow oxygen therapy?
Scientific title Treatment of central sleep apnoea and Cheyne Stokes respiration in patients with heart failure: nasal high-flow oxygen therapy? - Nasal high flow in heart failure patients with CSAS
Primary sponsor Universitair Medisch Centrum Groningen
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Not Recruiting
Study type Interventional
Phase 2
Countries The Netherlands
Conditions central sleep apnoea; sleep disorders breathing;10019280;10038716;central sleep apnoea; sleep disorders breathing
Interventions High Flow Therapy which is the application of humidified heated high-flow air, with or without the mixture with additional oxygen, through a nasal catheter. This therapy combines the positive effects of a certain level of continuous…
Registration date Jul 9, 2018
Target size 10
Secondary IDs NL61187.042.17;UMCG trial register 201700147
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations